Pharmaceutical Commerce

MARCH 10, 2025

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.

Pharmaceutical manufacturing 59

Pharmaceutical manufacturing Manufacturing Pharmaceutical Competition 59

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available.

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

World of DTC Marketing

APRIL 12, 2021

The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. Ironically, in later times, the intense competition for out-of-patent drugs has subsided, which has led to spiraling rises in generic drug prices and shortages.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

European Pharmaceutical Review

DECEMBER 6, 2023

In the interview, conducted at CPHI Barcelona, Krishna Venkatesh, Global Head, Sterile Manufacturing Operations at Dr Reddy’s Laboratories explores industry’s growing focus on achieving end-to-end connectivity, as well as the potential of automation and track and trace solutions. KV : We have seen two specific elements.

Manufacturing 98

Manufacturing Engineering Pharmaceutical manufacturing Pharmaceutical 98

PharmaTech

AUGUST 30, 2023

In pursuit of increased competitiveness and bottom-line impact, pharmaceutical manufacturers face increasing pressure to fast-track technological innovation while maintaining regulatory compliance. technology initiatives.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Competition Pharma 52

European Pharmaceutical Review

MARCH 1, 2024

UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing processes across the UK.” Curious about sustainability in pharmaceutical manufacturing and the supply chain?

Manufacturing 96

Manufacturing Pharmaceutical manufacturing Engineering Pharmaceutical 96

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Management 97

Management Food and Drug Administration Manufacturing Pharmaceutical manufacturing 97

pharmaphorum

DECEMBER 28, 2022

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. However, as we near the end of the year, there were some big moves.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

PM360

SEPTEMBER 30, 2024

This article outlines how developers can utilize sustainability initiatives to boost revenue, reduce costs, and advance innovation, ensuring a strategic, long-term, and more sustainable position in today’s competitive landscape. Implementing sustainable processes requires investigating every operational layer.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Impetus Digital

AUGUST 2, 2024

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. It also has the potential to reduce the high carbon footprint associated with manufacturing.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

European Pharmaceutical Review

FEBRUARY 10, 2025

AstraZeneca has scrapped its planned 450 million expansion of a vaccine manufacturing facility in Liverpool, UK, citing economic factors and reduced government funding. AstraZeneca remains committed to its UK operations but continues to assess opportunities in regions that offer more favourable financial conditions and regulatory support.

Government 52

Government Manufacturing Competition Pharmaceutical manufacturing 52

European Pharmaceutical Review

AUGUST 29, 2024

A major new £400 million public-private collaboration has launched in the UK, aimed at enhancing the life sciences sector’s economic growth and the competitiveness over the next five years. The innovative programme is set to strengthen clinical trials and improve medicine manufacturing in the UK.

Government 59

Government Pharma Competition Medicine 59

PM360

JANUARY 24, 2025

To effectively deliver a GVD and support a product launch, elements like quality- adjusted life years , comparative effectiveness data for payer negotiations, and competitive effectiveness summaries for marketing campaigns and sales pitches must be meticulously synthesized.

Marketing 64

Marketing Pharmaceutical Pharma Sales pitches 64

European Pharmaceutical Review

NOVEMBER 8, 2022

The new law will also require drug manufacturers to pay rebates to Medicare if they increase drug prices faster than consumer inflation. 3) policing anticompetitive settlements between competing drug manufacturers. 3) policing anticompetitive settlements between competing drug manufacturers. 5) monitoring access to biosimilars.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

pharmaphorum

NOVEMBER 25, 2022

Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. At the same time, Cattani urged for new rules in governing pharmaceutical expenditure, as even today, expenditure ceilings are inadequate with respect to real function. The situation was reversed only 25 years ago.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Competition 98

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Production of defossilised organic chemicals and materials.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

Pharmaceutical Technology

NOVEMBER 25, 2022

For pharmaceutical manufacturers and contract manufacturing organizations (CMOs) with containment capabilities, this likely means a distinct advantage over those without. Dedicated manufacturers are investing heavily in these services, powered by client requirements. A revolutionary development.

Manufacturing 52

Manufacturing Safety Pharmaceutical manufacturing Pharmaceutical 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Commercial dose companies form a critical component of the pharmaceutical manufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables. Discover the leading commercial dose companies in contract marketing.

Leads 40

Leads Marketing Sales Management Manufacturing 40

Contrarian Sales Techniques

FEBRUARY 26, 2023

While India and Italy are known for their active pharmaceutical ingredient (API) industries and production of generic drugs, other countries such as Brazil, Canada, South Korea, and others also have provisions for the manufacture and sale of generic drugs before the patent expires. of gross domestic product (GDP).

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

Pharmaceutical Technology

JULY 29, 2022

This is borne out of the fact that while nearly three-quarters are confident in the education and training for those in the pharma sector, just 64% are confident with the industry’s ability to source engineers against competition from other sectors. Manufacturing agility: Index score 6.5/10.

Biopharma 59

Biopharma Manufacturing Government Engineering 59

Pharmaceutical Technology

SEPTEMBER 15, 2022

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. This August, the Charleston Chamber Foundation won a competition ran by the US Department of Commerce, which will award an $8.4m-dollar

Medical 52

Medical Healthcare Healthcare Networking 52

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Pharmaceutical Technology

JULY 28, 2022

Investing in areas that have demonstrated a good track record of success for similar companies is a simple way to reduce risk, but in 2022, companies should be careful of investing in overly populated life sciences clusters, which might be too competitive. Discover why global life sciences businesses are choosing this thriving region.

Transportation 52

Transportation Education Marketing Networking 52

PM360

APRIL 25, 2023

Although AbbVie’s patent for Humira officially expired in 2016, the legal and regulatory delays paused competition for Humira until 2023. pharmaceutical industry. Financial incentives were explored further in the survey as biosimilars are expected to increase competition, thereby lower cost and increase access.

Marketing 97

Marketing Competition Government Manufacturing 97

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. The energy-related slowdown in manufacturing will aggravate the ongoing drug shortages in Europe.”

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105

Pharmaceutical Technology

FEBRUARY 3, 2023

Additionally, OSD manufacturing approaches are well developed, with processes that ensure a repeatable distribution of ingredients, uniformity in dissolution, and bioavailability, which verify that the drug product is safe and effective. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport.

Manufacturing 52

Manufacturing Pharmaceutical Transportation Pharmaceutical manufacturing 52

Pharmaceutical Technology

DECEMBER 19, 2022

To build an advanced pharmaceutical manufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceutical manufacturers. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised. But this results in huge, complex datasets.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

European Pharmaceutical Review

FEBRUARY 20, 2025

Supply chain vulnerabilities Introducing tariffs on pharmaceutical imports could lead to significant disruptions, particularly for generic medicines, which often rely on lower-cost API sourcing. 3 Pharmaceutical supply chains are highly dependent on international trade.

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20

Clarivate

AUGUST 20, 2024

Although the reported negotiated prices may ignore the real-world role of contracting by manufacturers and private payers over formulary placement, the reported prices nonetheless are likely to have downstream impacts on how private payers reimburse these therapies and their competitors.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52